QUANTUM PHARMACEUTICAL LIMITED
Get an alert when QUANTUM PHARMACEUTICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-10-08 (in 5mo)
Last made up 2025-09-24
Watchouts
None on the register
Cash
£3M
-4.4% vs 2023
Net assets
—
Equity attributable
Employees
250
-9.4% vs 2023
Profit before tax
£11M
-29.3% vs 2023
Name history
Renamed 1 time since incorporation
- QUANTUM PHARMACEUTICAL LIMITED 2010-11-19 → present
- QUANTUM SPECIALS LIMITED 2004-09-24 → 2010-11-19
Profit before tax
6-year trend · vs Health Care median
Accounts
6-year trend · latest reflected 2024-12-31
| Metric | Trend | 2019-06-30 | 2020-06-30 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | £15,983,242 | £11,304,361 | |
| Net profit | — | — | — | — | — | — | |
| Cash | — | — | — | — | £3,469,031 | £3,317,539 | |
| Total assets less current liabilities | — | — | — | — | — | — | |
| Net assets | — | — | — | — | — | — | |
| Equity | — | — | £3,455,518 | £4,688,369 | £15,421,960 | £23,779,568 | |
| Average employees | — | — | — | — | 276 | 250 | |
| Wages | — | — | — | — | £8,227,011 | £8,230,775 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Consilium Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “Turnover for the year ended 31 December 2024 grew by 15% to £200.4m (2023: £174.8m). This growth in revenue has been driven by capital investment made both this year and in the prior period which increased manufacturing capabilities in the year under review.”
- “Operating profit for the year ended 31 December 2024 declined to £12.3m (2023: £17.0m), with the Company's operating profit margin reducing to 6% (2023: 10%). This decline reflects a combination of strategic investment in the cost base and short-term margin pressures.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 29 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BARCLAY, Kenneth Edward | Director | 2026-02-06 | Aug 1978 | British |
| CAMPBELL, Lewis | Director | 2021-06-30 | Apr 1993 | British |
| DUNCAN, Stephen Peter | Director | 2021-07-14 | Apr 1986 | Scottish |
Show 29 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| EDGE, Ian | Secretary | 2004-09-24 | 2009-03-30 |
| MILLER, Amanda | Secretary | 2017-11-02 | 2021-06-30 |
| SCAIFE, Andrew John | Secretary | 2009-03-30 | 2010-01-29 |
| SUCH, Martin John | Secretary | 2010-01-29 | 2015-02-24 |
| SWINHOE, Craig Robert | Secretary | 2015-02-24 | 2017-11-02 |
| BARKER, Michael Denis | Director | 2015-06-18 | 2015-12-01 |
| BROWN, Catherine Jane | Director | 2016-03-16 | 2017-09-05 |
| BRYANT, David John | Director | 2019-02-01 | 2021-06-30 |
| BUYER, Victoria | Director | 2011-02-25 | 2011-10-07 |
| DICKINSON, Timothy David | Director | 2011-02-25 | 2013-04-26 |
| EDGE, Ian | Director | 2004-09-24 | 2010-09-08 |
| FISHER, Brian James | Director | 2012-01-27 | 2017-12-22 |
| GRANT, Gillian Margaret | Director | 2022-08-23 | 2025-02-24 |
| HUDSON, Kevin Robert | Director | 2005-04-06 | 2009-01-31 |
| LIDDLE, Stephen | Director | 2017-09-22 | 2018-01-12 |
| MATTHEWS, Andrew Paul | Director | 2011-07-04 | 2019-02-01 |
| MURRAY, Gerard Thomas | Director | 2017-01-23 | 2017-11-02 |
| PALING, Richard John | Director | 2019-03-19 | 2021-06-30 |
| PATTERSON, Andrew | Director | 2004-09-24 | 2009-01-31 |
| RICHARDSON, Phillip Dudley | Director | 2004-09-24 | 2009-01-31 |
| RIGG, Christian Alexander | Director | 2016-03-08 | 2017-01-27 |
| SANSON, David Alan | Director | 2021-07-14 | 2022-05-30 |
| SANSON, David Alan | Director | 2013-09-25 | 2021-06-30 |
| SCAIFE, Andrew John | Director | 2009-01-31 | 2015-12-01 |
| SUCH, Martin John | Director | 2010-01-29 | 2016-03-08 |
| SWINHOE, Craig Robert | Director | 2015-02-24 | 2015-12-01 |
| TAGG, Michael James | Director | 2017-12-01 | 2019-03-19 |
| THOMSON, Graham Ronald | Director | 2017-07-06 | 2018-06-30 |
| WATERS, Alison Anne | Director | 2004-09-24 | 2011-02-25 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Target Healthcare Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-07-06 | Active |
| Target Healthcare Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-06-30 | Ceased 2022-07-06 |
| Quantum Pharma Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Significant influence | 2016-09-24 | Ceased 2021-06-30 |
Filing timeline
Last 20 of 172 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-06 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-15 | CH01 | officers | Change person director company with change date | |
| 2025-12-15 | CH01 | officers | Change person director company with change date | |
| 2025-09-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-26 | AA | accounts | Accounts with accounts type full | |
| 2025-02-25 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-06 | CH01 | officers | Change person director company with change date | |
| 2024-09-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-05 | AA | accounts | Accounts with accounts type full | |
| 2024-02-20 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-02-05 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-09-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-09 | AA | accounts | Accounts with accounts type full | |
| 2022-09-28 | AA | accounts | Accounts with accounts type full | |
| 2022-09-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-15 | AP01 | officers | Appoint person director company with name date | |
| 2022-08-22 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2022-08-22 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-05-30 | TM01 | officers | Termination director company with name termination date | |
| 2022-02-21 | MR04 | mortgage | Mortgage satisfy charge full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
-4.4%
£3,469,031 £3,317,539
-
Net assets
—
Not reported
-
Employees
-9.4%
276 250
-
Profit before tax
-29.3%
£15,983,242 £11,304,361
-
Wages
0%
£8,227,011 £8,230,775
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers